Shanghai DZH Ltd (601519.SS) stock: key figures, P/E, revenue and dividend
Financials · Financial Exchanges & Data · China · ISIN CNE100000ZL9
Price
8.65 CNY
Market cap
17.21 bn CNY
P/E (2025)
–
P/S (2025)
20.94
Dividend yield
0.00 %
Net margin
-5.36 %
Return on equity (ROE)
-3.29 %
Return on assets (ROA)
-2.33 %
Shanghai DZH Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 770.85 m CNY | 821.82 m CNY |
| Gross profit | 462.48 m CNY | 478.03 m CNY |
| Operating income | -197.81 m CNY | -90.59 m CNY |
| EBIT | -195.56 m CNY | -90.59 m CNY |
| Net income | -201.27 m CNY | -44.03 m CNY |
| Diluted EPS – continuing operations | -0.10 CNY | -0.02 CNY |
Full history since 2007, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Shanghai DZH Ltd
Shanghai DZH Limited primarily operates as an Internet financial information service provider in China and internationally. It offers software, fund, private equity, and insurance services; and database, financial institutions, and great wisdom finance. The company was founded in 2000 and is headquartered in Shanghai, China.
More stocks
- People.Cn Co Ltd (603000.SS)
- Leyard Optoelectronic (300296.SZ)
- Shanghai Bairun Flavor & Fragrance Co Ltd (002568.SZ)
- Greenland Holdings Corp Ltd (600606.SS)
- Shurgard Self Storage SA (SHUR.BR)
- Hangzhou Cable (603618.SS)
- Liftoff Mobile, Inc. Common Stock (LFTO)
- Cushman & Wakefield Ltd. (CWK)
- Beijing Venustech Inc (002439.SZ)
- Asker Healthcare Group AB (ASKER.ST)
- Green Brick Partners, Inc. (GRBK)
- Nurix Therapeutics, Inc. (NRIX)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.